Skip to main content
. Author manuscript; available in PMC: 2016 Mar 14.
Published in final edited form as: Life Sci. 2014 Dec 11;122:1–7. doi: 10.1016/j.lfs.2014.12.001

Figure 6. Anti-TLR4 treatment abolishes noradrenaline-induced augmented ROS production in SHR.

Figure 6

The bar graphs represent a quantitative analysis of ROS production from mesenteric arteries of Wistar and SHR treated with IgG or anti-TLR4. On top of each graphs representative images of transverse DHE-treated sections of small mesenteric arteries stimulated with vehicle or noradrenaline. The results show densitometric analysis of fluorescence intensity of mesenteric arteries from Wistar and SHR treated with IgG or anti-TLR4 incubated with vehicle or noradrenaline and are expressed as mean ± SEM, (n= 4–5/group). *P < 0.05 vs respective group stimulated with noradrenaline. Statistical test: Student’s t test.